These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 36606199)

  • 21. A novel risk model construction and immune landscape analysis of gastric cancer based on cuproptosis-related long noncoding RNAs.
    Wang Y; Liu K; Shen K; Xiao J; Zhou X; Cheng Q; Hu L; Fan H; Ni P; Xu Z; Zhang D; Yang L
    Front Oncol; 2022; 12():1015235. PubMed ID: 36387229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
    Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
    J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer.
    Zhang Y; Li X; Li X; Zhao Y; Zhou T; Jiang X; Wen Y; Meng W; Li S
    Front Genet; 2022; 13():990326. PubMed ID: 36186475
    [No Abstract]   [Full Text] [Related]  

  • 24. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma.
    Zhou Y; Shu Q; Fu Z; Wang C; Gu J; Li J; Chen Y; Xie M
    Front Genet; 2022; 13():959456. PubMed ID: 35938036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer.
    Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F
    J Oncol; 2022; 2022():5034092. PubMed ID: 36276275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma.
    Zhu H; Mao F; Wang K; Feng J; Cheng S
    Front Genet; 2022; 13():972212. PubMed ID: 36212138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer.
    Huang J; Chen W; Chen C; Jie Z; Xiao T
    Int J Gen Med; 2022; 15():2629-2643. PubMed ID: 35300127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revealing prognostic and tumor microenvironment characteristics of cuproptosis in bladder cancer by genomic analysis.
    Zhang S; Yu S; Duan H; Xia W; Wang C; Shen H
    Front Genet; 2022; 13():997573. PubMed ID: 36263417
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.
    Xu C; Liu Y; Zhang Y; Gao L
    Front Genet; 2022; 13():928105. PubMed ID: 36313449
    [No Abstract]   [Full Text] [Related]  

  • 32. Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.
    Zhou P; Lu Y; Zhang Y; Wang L
    Front Oncol; 2021; 11():661758. PubMed ID: 34277410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
    Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
    Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma.
    Li H; Zu X; Hu J; Xiao Z; Cai Z; Gao N; Chen J
    Front Immunol; 2022; 13():964393. PubMed ID: 36211344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma.
    Han J; Hu Y; Liu S; Jiang J; Wang H
    J Oncol; 2022; 2022():8489387. PubMed ID: 35847354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma.
    Xu QS; Shen ZZ; Yuan LQ
    Front Cell Dev Biol; 2022; 10():968590. PubMed ID: 36467424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer.
    Zhu Z; Zhao Q; Song W; Weng J; Li S; Guo T; Zhu C; Xu Y
    Front Immunol; 2022; 13():940774. PubMed ID: 36248908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.